Concepedia

Mathew C. Finniss

MC

5

Publications

317

Citations

5

H-Index

2012

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

North Carolina State University

University of North Carolina at Chapel Hill

Carolina Institute for NanoMedicine

Mathew C. Finniss is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, pharmacology, and nanomedicine.

Top concepts

MedicinePharmacologyNanomedicineDrug DeliveryEngineeringNanoparticlesMedicinal ChemistryBiomolecular EngineeringChemistryBiopolymers

Publications per year

2012–2019

5

Publications

5

Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles

Matthew C. Parrott, Mathew C. Finniss, J. Chris Luft et al. · Journal of the American Chemical Society · 2012 · 125 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +22

Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy

Kevin S. Chu, Allison N. Schorzman, Mathew C. Finniss et al. · Biomaterials · 2013 · 121 citations · Full text

Nanoparticle Drug Loading, Nanomedicine, Pharmacology +8

Particle Replication in Nonwetting Templates Nanoparticles with Tumor Selective Alkyl Silyl Ether Docetaxel Prodrug Reduces Toxicity

Kevin S. Chu, Mathew C. Finniss, Allison N. Schorzman et al. · Nano Letters · 2014 · 45 citations · Full text

Nanoparticles, Engineering, Biomedical Engineering +17

A versatile acid-labile linker for antibody–drug conjugates

Mathew C. Finniss, Kevin S. Chu, Charles J. Bowerman et al. · MedChemComm · 2014 · 16 citations

Medicinal Chemistry, Versatile Acid-labile Linker, Pharmaceutical Science +10

A case of gastrointestinal histoplasmosis with esophageal involvement

Mathew C. Finniss, Paul Lewis, James W. Myers et al. · Clinical Journal of Gastroenterology · 2019 · 10 citations

Rows per page

1–5 of 5